Amryt (AMYT) Skin Disorder NDA Review Gets 3 Months Extension

Published on November 24, 2021

Amryt (AMYT) is seeking approval for Oleogel-S10 for treating epidermolysis bullosa, a rare genetic skin disorder, in the United States and Europe. The FDA extends the review period for the...

Continue reading on website
Other news

How to Separate the Champs From the Chumps in the Hiring Process

November 24, 2021
Ask candidates these 8 essential questions to ensure you find the best fit for the job.

How to Eliminate Imposter Syndrome Stress With One Simple Phrase, According to These First-Time Founders

November 24, 2021
Mina Park and Ricardo Marquez of Crispy Chicken social media agency discuss the launch and growth of their business.